Correction to: Ibalizumab: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 859, doi. 10.1007/s40265-018-0926-2
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 8
Results: 10
1
2
Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 857, doi. 10.1007/s40265-018-0925-3
- By:
- Publication type:
- Article
3
Mirabegron: A Review in Overactive Bladder Syndrome.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 833, doi. 10.1007/s40265-018-0924-4
- By:
- Publication type:
- Article
4
Colorectal Cancer: Why Does Side Matter?
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 789, doi. 10.1007/s40265-018-0921-7
- By:
- Publication type:
- Article
5
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 809, doi. 10.1007/s40265-018-0920-8
- By:
- Publication type:
- Article
6
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 853, doi. 10.1007/s40265-018-0919-1
- By:
- Publication type:
- Article
7
Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 851, doi. 10.1007/s40265-018-0918-2
- By:
- Publication type:
- Article
8
Tildrakizumab: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 845, doi. 10.1007/s40265-018-0917-3
- By:
- Publication type:
- Article
9
Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 799, doi. 10.1007/s40265-018-0915-5
- By:
- Publication type:
- Article
10
Management of Embolic Stroke of Undetermined Source (ESUS).
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 823, doi. 10.1007/s40265-018-0912-8
- By:
- Publication type:
- Article